Generate a tailored SOP for Dr. Jeremie Calais. Improve your application with a focused, well-structured draft.
Jeremie Calais is an Associate Professor in the Ahmanson Translational Theranostics Division of the Department of Molecular and Medical Pharmacology at UCLA. He received his MD degree from the University of Paris-Diderot in 2010 and trained in nuclear medicine cancer imaging at the Henri Becquerel Cancer Center, obtaining board certification from the French Society of Nuclear Medicine in 2014. His research is focused on improving outcomes for cancer patients through the translation of novel diagnostic and therapeutic approaches. He utilizes PET/CT imaging for cancer phenotyping, radiation therapy planning, and therapy response assessment. Dr. Calais leads a clinical research program that combines radionuclide therapy with imaging, addressing therapeutic opportunities in prostate cancer and neuroendocrine tumors. His clinical research involves collaborations across multiple departments at UCLA and engages in national and international investigative efforts. Moreover, he has played a key role in the development of theranostic pairs, contributing to advancements in clinical trials and innovative imaging techniques in oncology.
Ahmanson Translational Theranostics Division • Los Angeles, CA
Oversees the clinical research focusing on theranostic approaches combining imaging and targeted therapy.
Ahmanson Translational Theranostics Division • Los Angeles, CA
Teaches and conducts research in the field of nuclear medicine and molecular imaging.
Department of Economics admits primarily for the PhD program.